Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

S. Y. Park, K. J. Jeong, N. Panupinthu, S. Yu, J. Lee, J. W. Han, J. M. Kim, J. S. Lee, J. Kang, C. G. Park, Gordon Mills, H. Y. Lee

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Lysophosphatidic acid (LPA), produced extracellularly by autotaxin (ATX), has diverse biological activities implicated in tumor initiation and progression, including increasing cell survival, angiogenesis, invasion and metastasis. ATX, LPA and the matrix metalloproteinase (MMP)-9 have all been implicated in hepatocellular carcinoma (HCC) invasion and metastasis. We, thus sought to determine whether ATX with subsequent LPA production and action, including induction of MMP-9 could provide a unifying mechanism. ATX transcripts and LPA receptor type 1 (LPA1) protein are elevated in HCC compared with normal tissues. Silencing or pharmacological inhibition of LPA1 significantly attenuated LPA-induced MMP-9 expression and HCC cell invasion. Further, reducing MMP-9 activity or expression significantly inhibits LPA-induced HCC cell invasion, demonstrating that MMP-9 is downstream of LPA1. Inhibition of phosphoinositide-3 kinase (PI3K) signaling or dominant-negative mutants of protein kinase C and p38 mitogen-activated protein kinase (MAPK) abrogated LPA-induced MMP-9 expression and subsequent invasion. We thus demonstrate a mechanistic cascade of ATX-producing LPA with LPA activating LPA1 and inducing MMP-9 through coordinate activation of the PI3K and the p38 MPAK signaling cascades, providing novel biomarkers and potential therapeutic targets for HCC.

Original languageEnglish (US)
Pages (from-to)1351-1359
Number of pages9
JournalOncogene
Volume30
Issue number11
DOIs
StatePublished - Mar 17 2011
Externally publishedYes

Fingerprint

Lysophosphatidic Acid Receptors
Matrix Metalloproteinase 9
Hepatocellular Carcinoma
1-Phosphatidylinositol 4-Kinase
Neoplasm Metastasis
lysophosphatidic acid
p38 Mitogen-Activated Protein Kinases
Mutant Proteins
Protein Kinase C
Cell Survival
Biomarkers
Pharmacology

Keywords

  • human hepatocellular carcinoma cells
  • invasion
  • LPA1
  • lysophosphatidic acid
  • matrix metalloproteinase-9

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Park, S. Y., Jeong, K. J., Panupinthu, N., Yu, S., Lee, J., Han, J. W., ... Lee, H. Y. (2011). Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene, 30(11), 1351-1359. https://doi.org/10.1038/onc.2010.517

Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. / Park, S. Y.; Jeong, K. J.; Panupinthu, N.; Yu, S.; Lee, J.; Han, J. W.; Kim, J. M.; Lee, J. S.; Kang, J.; Park, C. G.; Mills, Gordon; Lee, H. Y.

In: Oncogene, Vol. 30, No. 11, 17.03.2011, p. 1351-1359.

Research output: Contribution to journalArticle

Park, SY, Jeong, KJ, Panupinthu, N, Yu, S, Lee, J, Han, JW, Kim, JM, Lee, JS, Kang, J, Park, CG, Mills, G & Lee, HY 2011, 'Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression', Oncogene, vol. 30, no. 11, pp. 1351-1359. https://doi.org/10.1038/onc.2010.517
Park, S. Y. ; Jeong, K. J. ; Panupinthu, N. ; Yu, S. ; Lee, J. ; Han, J. W. ; Kim, J. M. ; Lee, J. S. ; Kang, J. ; Park, C. G. ; Mills, Gordon ; Lee, H. Y. / Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. In: Oncogene. 2011 ; Vol. 30, No. 11. pp. 1351-1359.
@article{57e71f4eeb5044ce968347785b2c0d83,
title = "Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression",
abstract = "Lysophosphatidic acid (LPA), produced extracellularly by autotaxin (ATX), has diverse biological activities implicated in tumor initiation and progression, including increasing cell survival, angiogenesis, invasion and metastasis. ATX, LPA and the matrix metalloproteinase (MMP)-9 have all been implicated in hepatocellular carcinoma (HCC) invasion and metastasis. We, thus sought to determine whether ATX with subsequent LPA production and action, including induction of MMP-9 could provide a unifying mechanism. ATX transcripts and LPA receptor type 1 (LPA1) protein are elevated in HCC compared with normal tissues. Silencing or pharmacological inhibition of LPA1 significantly attenuated LPA-induced MMP-9 expression and HCC cell invasion. Further, reducing MMP-9 activity or expression significantly inhibits LPA-induced HCC cell invasion, demonstrating that MMP-9 is downstream of LPA1. Inhibition of phosphoinositide-3 kinase (PI3K) signaling or dominant-negative mutants of protein kinase C and p38 mitogen-activated protein kinase (MAPK) abrogated LPA-induced MMP-9 expression and subsequent invasion. We thus demonstrate a mechanistic cascade of ATX-producing LPA with LPA activating LPA1 and inducing MMP-9 through coordinate activation of the PI3K and the p38 MPAK signaling cascades, providing novel biomarkers and potential therapeutic targets for HCC.",
keywords = "human hepatocellular carcinoma cells, invasion, LPA1, lysophosphatidic acid, matrix metalloproteinase-9",
author = "Park, {S. Y.} and Jeong, {K. J.} and N. Panupinthu and S. Yu and J. Lee and Han, {J. W.} and Kim, {J. M.} and Lee, {J. S.} and J. Kang and Park, {C. G.} and Gordon Mills and Lee, {H. Y.}",
year = "2011",
month = "3",
day = "17",
doi = "10.1038/onc.2010.517",
language = "English (US)",
volume = "30",
pages = "1351--1359",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

AU - Park, S. Y.

AU - Jeong, K. J.

AU - Panupinthu, N.

AU - Yu, S.

AU - Lee, J.

AU - Han, J. W.

AU - Kim, J. M.

AU - Lee, J. S.

AU - Kang, J.

AU - Park, C. G.

AU - Mills, Gordon

AU - Lee, H. Y.

PY - 2011/3/17

Y1 - 2011/3/17

N2 - Lysophosphatidic acid (LPA), produced extracellularly by autotaxin (ATX), has diverse biological activities implicated in tumor initiation and progression, including increasing cell survival, angiogenesis, invasion and metastasis. ATX, LPA and the matrix metalloproteinase (MMP)-9 have all been implicated in hepatocellular carcinoma (HCC) invasion and metastasis. We, thus sought to determine whether ATX with subsequent LPA production and action, including induction of MMP-9 could provide a unifying mechanism. ATX transcripts and LPA receptor type 1 (LPA1) protein are elevated in HCC compared with normal tissues. Silencing or pharmacological inhibition of LPA1 significantly attenuated LPA-induced MMP-9 expression and HCC cell invasion. Further, reducing MMP-9 activity or expression significantly inhibits LPA-induced HCC cell invasion, demonstrating that MMP-9 is downstream of LPA1. Inhibition of phosphoinositide-3 kinase (PI3K) signaling or dominant-negative mutants of protein kinase C and p38 mitogen-activated protein kinase (MAPK) abrogated LPA-induced MMP-9 expression and subsequent invasion. We thus demonstrate a mechanistic cascade of ATX-producing LPA with LPA activating LPA1 and inducing MMP-9 through coordinate activation of the PI3K and the p38 MPAK signaling cascades, providing novel biomarkers and potential therapeutic targets for HCC.

AB - Lysophosphatidic acid (LPA), produced extracellularly by autotaxin (ATX), has diverse biological activities implicated in tumor initiation and progression, including increasing cell survival, angiogenesis, invasion and metastasis. ATX, LPA and the matrix metalloproteinase (MMP)-9 have all been implicated in hepatocellular carcinoma (HCC) invasion and metastasis. We, thus sought to determine whether ATX with subsequent LPA production and action, including induction of MMP-9 could provide a unifying mechanism. ATX transcripts and LPA receptor type 1 (LPA1) protein are elevated in HCC compared with normal tissues. Silencing or pharmacological inhibition of LPA1 significantly attenuated LPA-induced MMP-9 expression and HCC cell invasion. Further, reducing MMP-9 activity or expression significantly inhibits LPA-induced HCC cell invasion, demonstrating that MMP-9 is downstream of LPA1. Inhibition of phosphoinositide-3 kinase (PI3K) signaling or dominant-negative mutants of protein kinase C and p38 mitogen-activated protein kinase (MAPK) abrogated LPA-induced MMP-9 expression and subsequent invasion. We thus demonstrate a mechanistic cascade of ATX-producing LPA with LPA activating LPA1 and inducing MMP-9 through coordinate activation of the PI3K and the p38 MPAK signaling cascades, providing novel biomarkers and potential therapeutic targets for HCC.

KW - human hepatocellular carcinoma cells

KW - invasion

KW - LPA1

KW - lysophosphatidic acid

KW - matrix metalloproteinase-9

UR - http://www.scopus.com/inward/record.url?scp=79952745018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952745018&partnerID=8YFLogxK

U2 - 10.1038/onc.2010.517

DO - 10.1038/onc.2010.517

M3 - Article

VL - 30

SP - 1351

EP - 1359

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 11

ER -